One of the world's oldest blood pressure drugs may also halt aggressive brain tumor growth

World’s oldest blood pressure drug may help treat aggressive brain tumour

A study from the University of Pennsylvania reveals how hydralazine, an old blood pressure medication, may halt the growth of aggressive brain cancers, unveiling new treatment possibilities.

Fast-growing cancer could be slowed by common blood pressure drug, research shows

University of Pennsylvania researchers discovered how the decades-old blood pressure drug hydralazine could double as a new glioblastoma treatment.

One of the world's oldest blood pressure drugs may also halt aggressive brain tumor growth

A Penn-led team has revealed how hydralazine, one of the world's oldest blood pressure drugs and a mainstay treatment for preeclampsia, works at the molecular level. In doing so, they made a surprising discovery—it can also halt the growth of aggressive brain tumors.